The PLANES model for unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization plus lenvatinib and PD-1 inhibitors: a multicenter, retrospective study
The PLANES model was successfully established and validated for predict prognosis in unresectable HCC patients receiving first-line triple therapy.
Authors
- Zhenxin Zeng
- Jiayi Wu (ORCID: https://orcid.org/0000-0002-2645-6060)
- Junyi Wu (ORCID: https://orcid.org/0000-0001-5167-1822)
- Yinan Li (ORCID: https://orcid.org/0009-0001-1263-3556)
- Maolin Yan (ORCID: https://orcid.org/0000-0002-9852-2661)
- Huachun Song
- Shuqun Li
- Houxiang Ya
- Kai Wang
- Xiangye Ou
Institutions
- Guilin Medical University (CN)
- Fujian Provincial Hospital (CN)
- Southern Medical University Shenzhen Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-15
- DOI
- https://doi.org/10.3389/fimmu.2025.1680956
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Fujian Province
- Natural Science Foundation of Guangxi Province
- Fujian Provincial Health Commission